The Latest ddPCR Technology for Mutation Detection Multiplexing
Precise and rapid mutation detection is critical to the advancement of cancer research. In addition, patient outcomes can depend on the rapid mutation identification workflows.
Compared to other methods, Droplet Digital™ PCR (ddPCR™) allows researchers to detect rare mutations at very low fractional abundance, with faster turnaround times and at lower costs.
This app note highlights the latest ddPCR solutions for advanced assay multiplexing. It demonstrates how researchers can get the most out of precious clinical samples, with time and cost-saving advantages over gene sequencing methods.
Download this app note to discover:
- The wider benefits of ddPCR over next-generation sequencing technology
- Mutation detection examples that can be applied to multiple cancer types
- An elegant 6-plex solution that leverages both sensitivity and accuracy